198 related articles for article (PubMed ID: 10146992)
1. Pharmacoeconomics of immunisation: a review.
van den Oever R; de Graeve D; Hepp B; Stroobant A; Walckiers D; Van Casteren V; Van Loock F; Ducoffre G; Dewatripont J; Jacques P
Pharmacoeconomics; 1993 Apr; 3(4):286-308. PubMed ID: 10146992
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
4. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
5. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
6. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
[TBL] [Abstract][Full Text] [Related]
7. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of the routine childhood immunization program in the United States, 2009.
Zhou F; Shefer A; Wenger J; Messonnier M; Wang LY; Lopez A; Moore M; Murphy TV; Cortese M; Rodewald L
Pediatrics; 2014 Apr; 133(4):577-85. PubMed ID: 24590750
[TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae type b conjugate vaccine use and effectiveness.
Morris SK; Moss WJ; Halsey N
Lancet Infect Dis; 2008 Jul; 8(7):435-43. PubMed ID: 18582836
[TBL] [Abstract][Full Text] [Related]
10. Considering economic analyses in the revision of the preventive vaccination law: a new direction for health policy-making in Japan?
Akazawa M; Yongue J; Ikeda S; Satoh T
Health Policy; 2014 Oct; 118(1):127-34. PubMed ID: 25139708
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
Holliday SM; Faulds D
Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
[TBL] [Abstract][Full Text] [Related]
12. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
[TBL] [Abstract][Full Text] [Related]
13. [Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme].
Boot HJ; Schouls L; Hahné S; Berbers GA; van de Laar M; Kimman TG
Ned Tijdschr Geneeskd; 2007 Jan; 151(3):172-6. PubMed ID: 17288341
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
15. [Eradication of infectious diseases and vaccination].
Bégué P
Bull Acad Natl Med; 2001; 185(4):777-84. PubMed ID: 11503363
[TBL] [Abstract][Full Text] [Related]
16. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
[TBL] [Abstract][Full Text] [Related]
17. Andean region: measles on the way out.
EPI Newsl; 1996 Oct; 18(5):1-3. PubMed ID: 12320547
[TBL] [Abstract][Full Text] [Related]
18. Trends and determinants of immunisation coverage in India.
Suresh K; Saxena D
J Indian Med Assoc; 2000 Jan; 98(1):10-4. PubMed ID: 11016138
[TBL] [Abstract][Full Text] [Related]
19. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies.
Edmunds WJ
Commun Dis Public Health; 1998 Dec; 1(4):221-8. PubMed ID: 9854877
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
